12
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Interaction of the D1 Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP Syndrome

, , , , &
Pages 107-120 | Published online: 26 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Bischoff, J. Krauss, C. Grunenwald, F. Gunst, M. Heinrich, M. Schaub, K. Stöcklin, A. Vassout, P. Waldmeier & L. Maître. (1991) Endogenous Dopamine (Da) Modulates [3H]spiperone Binding in Vivo in Rat Brain. Journal of Receptor Research 11:1-4, pages 163-175.
Read now

Articles from other publishers (34)

Sophia T. Papadeas & George R. Breese. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity 377 441 .
Soroush Darvish-Ghane, Clémentine Quintana, Jean-Martin Beaulieu & Loren J. Martin. (2020) D1 receptors in the anterior cingulate cortex modulate basal mechanical sensitivity threshold and glutamatergic synaptic transmission. Molecular Brain 13:1.
Crossref
Simon A. Sharples, Nicole E. Burma, Joanna Borowska-Fielding, Charlie H. T. Kwok, Shane E. A. Eaton, Glen B. Baker, Celine Jean-Xavier, Ying Zhang, Tuan Trang & Patrick J. Whelan. (2020) A dynamic role for dopamine receptors in the control of mammalian spinal networks. Scientific Reports 10:1.
Crossref
Daniel E. Felsing, Manish K. Jain & John A. Allen. (2019) Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics. Current Topics in Medicinal Chemistry 19:16, pages 1365-1380.
Crossref
Laura M. Tormoehlen & Daniel E. Rusyniak. 2018. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II 663 675 .
Yuki Aoyama, Akihiro Mouri, Kazuya Toriumi, Takenao Koseki, Shiho Narusawa, Natsumi Ikawa, Takayoshi Mamiya, Taku Nagai, Kiyofumi Yamada & Toshitaka Nabeshima. (2013) Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor. The International Journal of Neuropsychopharmacology 17:05, pages 723-737.
Crossref
Sophia T. Papadeas & George R. Breese. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity 133 198 .
M. Victoria Puig & Earl K. Miller. (2012) The Role of Prefrontal Dopamine D1 Receptors in the Neural Mechanisms of Associative Learning. Neuron 74:5, pages 874-886.
Crossref
Genevieve Beauvais, Kenisha Atwell, Subramaniam Jayanthi, Bruce Ladenheim & Jean Lud Cadet. (2011) Involvement of Dopamine Receptors in Binge Methamphetamine-Induced Activation of Endoplasmic Reticulum and Mitochondrial Stress Pathways. PLoS ONE 6:12, pages e28946.
Crossref
Dayong Wang, Yukihiro Noda, Yuan Zhou, Atsumi Nitta, Hiroshi Furukawa & Toshitaka Nabeshima. (2007) Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. Neuropharmacology 53:3, pages 379-389.
Crossref
Alexandra Hamacher, Mathias Weigt, Michael Wiese, Barbara Hoefgen, Jochen Lehmann & Matthias U Kassack. (2006) Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis. BMC Pharmacology 6:1.
Crossref
Judith Schweimer & Wolfgang Hauber. (2006) Dopamine D1 receptors in the anterior cingulate cortex regulate effort-based decision making. Learning & Memory 13:6, pages 777-782.
Crossref
Christopher M. Olsen & Christine L. Duvauchelle. (2006) Prefrontal cortex D1 modulation of the reinforcing properties of cocaine. Brain Research 1075:1, pages 229-235.
Crossref
Antonieta Lavin, Lourdes Nogueira, Christopher C. Lapish, R. Mark Wightman, Paul E. M. Phillips & Jeremy K. Seamans. (2005) Mesocortical Dopamine Neurons Operate in Distinct Temporal Domains Using Multimodal Signaling. The Journal of Neuroscience 25:20, pages 5013-5023.
Crossref
Amy F MacDonald, Charles J Billington & Allen S Levine. (2004) Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Research 1018:1, pages 78-85.
Crossref
Sophia T. Papadeas, Bonita L. Blake, Darin J. Knapp & George R. Breese. (2004) Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D 1 -Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement . The Journal of Neuroscience 24:26, pages 5863-5876.
Crossref
Michael E. Ragozzino. (2002) The Effects of Dopamine D 1 Receptor Blockade in the Prelimbic–Infralimbic Areas on Behavioral Flexibility . Learning & Memory 9:1, pages 18-28.
Crossref
Christopher M Olsen & Christine L Duvauchelle. (2001) Intra-prefrontal cortex injections of SCH 23390 influence nucleus accumbens dopamine levels 24 h post-infusion. Brain Research 922:1, pages 80-86.
Crossref
Heinz Steiner & Stephen T. Kitai. (2000) Regulation of Rat Cortex Function by D1 Dopamine Receptors in the Striatum. The Journal of Neuroscience 20:14, pages 5449-5460.
Crossref
Sylvie Granon, Filippo Passetti, Kerrie L. Thomas, Jeffrey W. Dalley, Barry J. Everitt & Trevor W. Robbins. (2000) Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex. The Journal of Neuroscience 20:3, pages 1208-1215.
Crossref
Elizabeth D. Abercrombie & Peter DeBoer. (1997) Substantia Nigra D 1 Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism . The Journal of Neuroscience 17:21, pages 8498-8505.
Crossref
Éva Hajós-Korcsok & Trevor Sharp. (1996) 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. European Journal of Pharmacology 314:3, pages 285-291.
Crossref
William L. Thomas, Erick S. Cooke & Ronald P. HammerJr.Jr.. (1995) Pretreatment with a dopamine D1-receptor antagonist prevents metabolic activation by cocaine. Neuroscience Letters 196:2, pages 161-164.
Crossref
T. Sumiyoshi, H. Kido, H. Sakamoto, K. Urasaki, K. Suzuki, N. Yamaguchi, H. Mori & K. Shiba. (1994) Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo. Pharmacology Biochemistry and Behavior 49:1, pages 165-169.
Crossref
R. Corbett, H. Hartman, L.L. Kerman, A.T. Woods, J.T. Strupczewski, G.C. Helsley, P.C. Conway & R.W. Dunn. (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacology Biochemistry and Behavior 45:1, pages 9-17.
Crossref
J.P. Herman, F. Rouge-Pont, M. Le Moal & D.N. Abrous. (1993) Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: A pharmacological and biochemical analysis. Neuroscience 53:4, pages 1083-1095.
Crossref
Clark A. Briggs, Nancy J. Pollock, Donald E. Frail, Cheryl L. Paxson, Robert F. Rakowski, Chae Hee Kang & John W. Kebabian. (2012) Activation of the 5‐HT 1c receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393 . British Journal of Pharmacology 104:4, pages 1038-1044.
Crossref
P. Govitrapong, V. Prapapanich & M. Ebadi. (1991) Identification of serotonin 5HT 2 receptors in bovine pineal gland . Journal of Pineal Research 11:3-4, pages 182-187.
Crossref
D.R. Britton, P. Curzon, R.G. Mackenzie, J.W. Kebabian, J.E.G. Williams & D. Kerkman. (1991) Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacology Biochemistry and Behavior 39:4, pages 911-915.
Crossref
A.C. Towle, H.E. Criswell, E.H. Maynard, J.M. Lauder, T.H. Joh, R.A. Mueller & G.R. Breese. (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study. Pharmacology Biochemistry and Behavior 34:2, pages 367-374.
Crossref
James S. New & Katherine S. Takaki. 1989. 1 10 .
Herbert Y. Meltzer. (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:S1, pages S18-S27.
Crossref
James A. Temlett, Piang Ngok Chong, Wolfgang H. Oertel, Peter Jenner & C. David Marsden. (1988) The D-1 dopamine receptor partial agonist, CY 208–243, exhibits antiparkinsonian activity in the MPTP-treated marmoset. European Journal of Pharmacology 156:2, pages 197-206.
Crossref
Robert D. McQuade, David Ford, Ruth A. Duffy, Richard E. Chipkin, Louis C. Iorio & Allen Barnett. (1988) Serotonergic component of SCH 23390: In vitro and in vivo binding analyses. Life Sciences 43:23, pages 1861-1869.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.